Cowan Elvia
SVP, Finance & CAO
Cowan Elvia has filed 12 SEC Form 4 filings (31 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Nov 4, 2026.
On the most recent filing, Cowan Elvia is listed as SVP, Finance & CAO at Vaxcyte, Inc. Inside the rolling window, Cowan Elvia reported no open-market purchases and 6 open-market sales totaling $2.8M in PCVX. The largest disclosed transaction in the window is a sale of 19,000 PCVX shares on Oct 5, 2026, worth $1.6M.
Companies traded
Other insiders at PCVX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.8M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Cowan Elvia made?
Cowan Elvia has filed 12 SEC Form 4 filings (31 transaction rows) across 1 company since 2025.
Which companies does Cowan Elvia trade?
Cowan Elvia has filed SEC Form 4 disclosures for 1 company, including PCVX.
When was Cowan Elvia's most recent SEC Form 4 filing?
Cowan Elvia's most recent SEC Form 4 filing on Tracefour is dated Nov 4, 2026.
What is Cowan Elvia's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Cowan Elvia is listed as SVP, Finance & CAO.
What is Cowan Elvia's total buy and sell value in the current window?
Inside the rolling retention window, Cowan Elvia bought $0 and sold $2.8M based on SEC Form 4 filings.
What was Cowan Elvia's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 19,000 PCVX shares on 2026-10-05, worth $1.6M, per SEC Form 4 filings.